Diabetes Mellitus, Type 2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Obesity
  • BMI-CDS
  • (no location specified)
2022-01-06
Jan 6, 2022
G
Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Near-infrared (NIR)
  • (no location specified)
2022-01-17
Jan 17, 2022
G
Not yet recruiting
  • Inflammatory Bowel Diseases
  • Diabetes Mellitus, Type 2
  • GLP1 analogues
  • Paris, France
    Groupe Hospitalier Paris Saint-Joseph
2022-01-18
Jan 18, 2022
N
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin Icodec
  • Buena Park, California
  • +71 more
2022-01-13
Jan 13, 2022
N
Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +68 more
2022-01-12
Jan 12, 2022
N
Recruiting
  • Diabetes Mellitus, Type 2
  • semaglutide
  • oral glucose-lowering medications (commercially available)
  • Alhambra, California
  • +18 more
2022-01-12
Jan 12, 2022
N
Active, not recruiting
  • Overweight
  • +2 more
  • Aparecida de Goiania, Goias, Brazil
  • +28 more
2022-01-12
Jan 12, 2022
C
Recruiting
  • Diabetes Mellitus, Type 2
  • Virta Health
  • Craig, Colorado
  • +2 more
2022-01-11
Jan 11, 2022
N
Completed
  • Diabetes Mellitus, Type 2
  • New Find-risk questionnaire software
  • Pozzilli, IS, Italy
    IRCCS INM Neuromed, Department of Epidemiology and Prevention
2022-01-11
Jan 11, 2022
S
Recruiting
  • Angiotensin/Renin/Aldosterone Hypertension
  • +2 more
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
2021-12-27
Dec 27, 2021
D
Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
    • Ulm, Baden-Württemberg, Germany
      Institut für Diabetes-Technologie Forschungs- und Entwicklungsge
    2022-01-11
    Jan 11, 2022
    B
    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • empagliflozin
    • Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents
    • Ingelheim am Rhein, Germany
      Boehringer Ingelheim International GmbH
    2022-01-11
    Jan 11, 2022
    N
    U
    Recruiting
    • Diet, Healthy
    • +2 more
    • Healthy food incentive
    • Healthy food prescription
    • Multiple Locations, Alberta, Canada
      Primary Care Clinics
    2021-12-30
    Dec 30, 2021
    I
    Terminated
    • Diabetes Mellitus, Type 2
    • +2 more
    • Falls Church, Virginia
      Inova Fairfax Hospital
    2021-12-23
    Dec 23, 2021
    N
    Completed
    • Weight Gain
    • +4 more
      • Phoenix, Arizona
        NIDDK, Phoenix
      2022-01-11
      Jan 11, 2022
      N
      Completed
      • Obesity
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-01-11
        Jan 11, 2022
        B
        Active, not recruiting
        • Diabetes Mellitus, Type 2
        • Aarhus, Denmark
          Department of Clinical Epidemiology - Aarhus Unversiteteshospita
        2022-01-10
        Jan 10, 2022
        B
        Active, not recruiting
        • Diabetes Mellitus, Type 2
        • Beijing, China
        • +23 more
        2022-01-10
        Jan 10, 2022
        B
        Not yet recruiting
        • Diabetes Mellitus, Type 2
        • (no location specified)
        2022-01-10
        Jan 10, 2022
        N
        Completed
        • Diabetes Mellitus, Type 2
        • Exercise behavior change for resistance exercise
        • Taipei, Taiwan
          Shin Kong Wu Ho-Su Memorial Hospital
        2022-01-10
        Jan 10, 2022
        N
        Completed
        • Heart Failure, Diastolic
        • Diabetes Mellitus, Type 2
        • Moscow, Russian Federation
          National Medical Research Center for Cardiology
        2022-01-10
        Jan 10, 2022
        B
        Active, not recruiting
        • Diabetes Mellitus, Type 2
        • Cardiovascular Diseases
        • Ridgefield, Connecticut
          Boehringer Ingelheim Pharmaceuticals Inc
        2022-01-10
        Jan 10, 2022